Jeff Gross, MD | Stem Cells, Regenerative Medicine & Longevity
In this episode of the Rest and Recovered podcast, Dr. Jeffrey Gross, a board-certified and fellowship-trained neurosurgeon, discusses his background and the evolution of his practice. With a degree in Biochemistry, Dr. Gross has a strong interest in cellular function and molecular biology. After over 20 years of practicing neurosurgery, particularly spinal neurosurgery, Dr. Gross […]
A New Hope: Umbilical Cord Blood Stem Cells Expand Access to HIV Cures
Mixed-race woman with both HIV and acute leukemia received a stem cell transplant using umbilical cord blood stem cells with a CCR5-delta32 mutation, which confers resistance to HIV. This modified approach may expand the pool of available stem cells for curing HIV in people needing transplants for other medical conditions. The patient’s leukemia remains in […]
Father’s Gift of Life: Young Cancer Warrior Levi Triumphs with Dad’s Stem Cell Help
7-year-old Levi Galvez celebrated being cancer-free at Riley Hospital in Indianapolis on March 27, after a five-year battle with leukemia that began when he was two years old. His father, Geovani Galvez, provided a life-saving stem cell transplant a year ago. The family celebrated the milestone with cheers, laughter, and a small ceremony. Geovani, who […]
BioCardia Announces Issuance of Two Patents Related to Technology That Guides Interventional Therapies
SUNNYVALE, Calif., April 04, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the issuance of two patent grants related to enabling technologies for delivery of its investigational autologous and allogeneic cell therapies. The United States Patent Office issued BioCardia Patent […]
Unraveling the Wonders of Stem Cells: A Comprehensive Guide
This video from Nomadic Science provides a comprehensive overview of stem cells, their types, sources, applications in medicine, ethical considerations, and the future of stem cell research. Stem cells are unique cells with the ability to self-renew and differentiate into various cell types, offering immense potential to revolutionize medicine and healthcare. Types of stem cells […]
Investing in Your Family’s Future: A Tour of CBR’s State-of-the-Art Stem Cell Facility
Dr. Ali Rodriguez has been invited by CBR to tour their state-of-the-art facility in Tucson, Arizona, which specializes in processing and storing umbilical cord stem cells. CBR, operational for 30 years, has processed nearly a million stem cell collections from families worldwide. Their 80,000 square foot laboratory, the largest newborn stem cell bank globally, uses […]
Beyond Organ Transplants: The Power of Cell Transformation and Rejuvenation
The video discusses two major problems in modern medicine: the shortage of organs for transplantation and age-related diseases. Prof. Yossi Buganim’s lab focuses on transforming cells, such as converting skin cells into various other cell types, to create an unlimited source of cells for transplantation. This approach aims to address the organ shortage problem. Additionally, […]
Top Five Stem Cell and PRP Myths with Dr. Centeno
In this recording of a recent live stream, Dr. Centeno, an expert in regenerative medicine who will be debunking the top five myths surrounding stem cells and platelet-rich plasma (PRP) therapy. As misinformation continues to circulate in the rapidly evolving field of regenerative medicine, it’s crucial to separate fact from fiction. Dr. Centeno, with his […]
Successful Growth of Functional Thymus Organoids from Human Stem Cells
The thymus, a crucial organ for adaptive immune response, produces T cells that attack invaders. With age and certain diseases, the thymus degrades, affecting immunity. Scientists from the University of Florida have grown functional thymus organoids from human stem cells for the first time, potentially aiding the development of patient-specific therapies for thymic dysfunction. Although […]
BrainStorm Cell Therapeutics Announces FDA Advisory Committee Meeting to Review Biologics License Application for NurOwn® for the Treatment of ALS
NEW YORK, March 27, 2023 /PRNewswire/ — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) will hold an Advisory Committee Meeting (‘ADCOM’) to discuss the company’s Biologics License Application (BLA) for NurOwn® for the treatment of amyotrophic lateral sclerosis (ALS). Given the […]